The Pfizer-BioNTech COVID-19 vaccine became the first vaccine to receive the World Health Organisation (WHO) validation for emergency use since the pandemic outbreak.
“Regulatory experts from around the world reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy and quality. They found that the vaccine met the must-have criteria for safety, efficacy and that the benefits of using it to address the disease offset potential risks,” WHO Tweeted.
The Pfizer/BioNTech #COVID19 vaccine today became the first vaccine to receive WHO validation for emergency use since the outbreak began.
— World Health Organization (WHO) (@WHO) December 31, 2020
Equitable global access to vaccines is crucial to combat the pandemic.
👉 https://t.co/7WNcHhc3z8 pic.twitter.com/Kyjv5RNzjB
Regulatory experts from around the 🌐 reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy & quality. They found that the vaccine met the must-have criteria for safety & efficacy & that the benefits of using it to address the disease offset potential risks pic.twitter.com/XSCQIDlw9b
— World Health Organization (WHO) (@WHO) December 31, 2020
At least 47 dead in eastern Indonesia after magnitude 7.7 quake
Yemen's Mocha port halts operations after Houthi attacks, port director says
Israeli strikes kill 11 in south Lebanon, health ministry says
Trump says he will soon declare Strait of Hormuz a US territory
Yemen government says Houthi missiles kill four in port city
